The Pulmozyme Access Solutions team at Genentech is available to provide the following services for people with cystic fibrosis:

• A Reimbursement Assistance Hotline 
• Thorough Benefits Investigations and Prior Authorization Assistance
• A Dedicated Pulmozyme Access Solutions Case Manager
• Appeals Assistance for Coverage Denials
• An Alternative Funding Specialist for Referrals to Co-pay Assistance Organizations
• The Genentech^® Access to Care Foundation for qualifying uninsured or under-insured patients 
• The Pulmozyme StarteRx Program for first-time users of Pulmozyme
• Information Resources via www.PulmozymeAccessSolutions.com

In conjunction with the launch of Pulmozyme Access Solutions, the Genentech Endowment for Cystic Fibrosis stopped accepting new patients on February 1, 2008 and will end operations on March 31, 2008.

If you are interested in learning more about or enrolling in Pulmozyme Access Solutions, please call the Pulmozyme Access Solutions team at 1-800-690-3023, Monday through Friday, 6 a.m. to 5 p.m. PST, or visit www.PulmozymeAccessSolutions.com.

For well over a decade, the Genentech Endowment for Cystic Fibrosis has provided assistance to many people with CF who have been prescribed Pulmozyme. We are proud of the services we have provided, the high standards we set, and our commitment to patients. With Pulmozyme Access Solutions, we are expanding our commitment to patients, and we will continue to seek out new and better ways to solve issues related to coverage and reimbursement until access ceases to be a problem for any of the patients we serve.